Biotech News

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

Hyperfine (HYPR)HyperfineConference / presentation

Prospective randomized ED study shows rapid bedside imaging, detection of critical neurological findings, and potential workflow efficiency benefits with portable MRI GUILFORD, Conn. --(BUSINESS WIRE)--May 22, 2026-- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that

Related news

Hyperfine

Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of...

Recent company news

Stock data

Close
0.98 USD
Market cap
148.91M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States